VolitionRx Ltd
VNRX
25 hedge funds and large institutions have $4.99M invested in VolitionRx Ltd in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
0.07% less ownership
Funds ownership: 0.46% → 0.39% (-0.07%)
7% less funds holding
Funds holding: 27 → 25 (-2)
41% less capital invested
Capital invested by funds: $8.4M → $4.99M (-$3.42M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$70K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.5K |
| 3 |
Bank of New York Mellon
New York
|
+$44.2K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$11.9K |
| 5 |
OC
Oppenheimer & Co
New York
|
+$4.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$916K |
| 2 |
LIM
Lagoda Investment Management
New York
|
-$406K |
| 3 |
VF
Virtu Financial
New York
|
-$49K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$36.5K |
| 5 |
LCM
Leisure Capital Management
Costa Mesa,
California
|
-$14.6K |
VNRX Hedge Fund Activity: Q4 2018 in Review
25 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q4 2018, worth a combined $4.99M — down 41% from $8.4M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of VNRX and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 6 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $70K. The largest seller was Knoll Capital Management, exiting entirely with an estimated $916K sold.
- 25 institutional investors held VolitionRx Ltd (VNRX) as of Q4 2018, down from 27 in Q3 2018.
- Funds reported $4.99M of VolitionRx Ltd stock for Q4 2018, down 41% quarter-over-quarter.
- 2 funds opened new VolitionRx Ltd positions in Q4 2018 and 4 closed out, a net change of -2 holders.
- The largest VolitionRx Ltd buyer in Q4 2018 was Susquehanna International Group, an estimated $70K added.
- The largest VolitionRx Ltd seller in Q4 2018 was Knoll Capital Management, an estimated $916K sold.
Based on aggregated 13F filings for Q4 2018.